Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-024051

President and CEO sold 300 shares at $15.00 ($4,500)

  • President and CEO acquired 300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
McCarthy Sean A. President and CEO 2017-06-05 Option exercise +300 $0.95 $284 4,545 D
McCarthy Sean A. President and CEO 2017-06-05 Sale −300 $15.00 $4,500 4,245 D
Derivatives
McCarthy Sean A. President and CEO 2017-06-05 Option exercise · Stock Option (right to buy) −300 67,772 D
Open-market sales · 300 sh · avg $15.00 · $4,500
Loading xslF345X03/doc1.xml…